X4 Pharmaceuticals Statistics
Total Valuation
XFOR has a market cap or net worth of $19.33 million. The enterprise value is $10.42 million.
Important Dates
The last earnings date was Thursday, May 1, 2025, before market open.
| Earnings Date | May 1, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
XFOR has 5.79 million shares outstanding. The number of shares has increased by 5.89% in one year.
| Current Share Class | 5.79M |
| Shares Outstanding | 5.79M |
| Shares Change (YoY) | +5.89% |
| Shares Change (QoQ) | +1.55% |
| Owned by Insiders (%) | 5.67% |
| Owned by Institutions (%) | 39.53% |
| Float | 4.40M |
Valuation Ratios
The trailing PE ratio is 1.54.
| PE Ratio | 1.54 |
| Forward PE | n/a |
| PS Ratio | 0.72 |
| Forward PS | 2.01 |
| PB Ratio | 0.84 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | 0.71 |
| EV / Sales | 0.33 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.70, with a Debt / Equity ratio of 3.40.
| Current Ratio | 3.70 |
| Quick Ratio | 3.40 |
| Debt / Equity | 3.40 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -12.49 |
Financial Efficiency
Return on equity (ROE) is 121.75% and return on invested capital (ROIC) is -88.55%.
| Return on Equity (ROE) | 121.75% |
| Return on Assets (ROA) | -58.61% |
| Return on Invested Capital (ROIC) | -88.55% |
| Return on Capital Employed (ROCE) | -109.05% |
| Revenue Per Employee | $219,329 |
| Profits Per Employee | $102,084 |
| Employee Count | 143 |
| Asset Turnover | 0.26 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, XFOR has paid $325,000 in taxes.
| Income Tax | 325,000 |
| Effective Tax Rate | 2.18% |
Stock Price Statistics
The stock price has decreased by -89.40% in the last 52 weeks. The beta is 0.73, so XFOR's price volatility has been lower than the market average.
| Beta (5Y) | 0.73 |
| 52-Week Price Change | -89.40% |
| 50-Day Moving Average | 6.98 |
| 200-Day Moving Average | 14.93 |
| Relative Strength Index (RSI) | 22.02 |
| Average Volume (20 Days) | 152,276 |
Short Selling Information
The latest short interest is 290,703, so 5.02% of the outstanding shares have been sold short.
| Short Interest | 290,703 |
| Short Previous Month | 8.80M |
| Short % of Shares Out | 5.02% |
| Short % of Float | 6.61% |
| Short Ratio (days to cover) | 4.73 |
Income Statement
In the last 12 months, XFOR had revenue of $31.36 million and earned $14.60 million in profits. Earnings per share was $2.16.
| Revenue | 31.36M |
| Gross Profit | 25.85M |
| Operating Income | -113.56M |
| Pretax Income | 17.73M |
| Net Income | 14.60M |
| EBITDA | -112.35M |
| EBIT | -113.56M |
| Earnings Per Share (EPS) | $2.16 |
Full Income StatementBalance Sheet
The company has $86.95 million in cash and $78.04 million in debt, giving a net cash position of $8.91 million or $1.54 per share.
| Cash & Cash Equivalents | 86.95M |
| Total Debt | 78.04M |
| Net Cash | 8.91M |
| Net Cash Per Share | $1.54 |
| Equity (Book Value) | 22.94M |
| Book Value Per Share | 3.96 |
| Working Capital | 69.81M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$109.67 million and capital expenditures -$267,000, giving a free cash flow of -$109.94 million.
| Operating Cash Flow | -109.67M |
| Capital Expenditures | -267,000 |
| Free Cash Flow | -109.94M |
| FCF Per Share | -$18.99 |
Full Cash Flow StatementMargins
Gross margin is 82.42%, with operating and profit margins of -362.06% and 46.54%.
| Gross Margin | 82.42% |
| Operating Margin | -362.06% |
| Pretax Margin | 47.58% |
| Profit Margin | 46.54% |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
XFOR does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -5.89% |
| Shareholder Yield | -5.89% |
| Earnings Yield | 75.50% |
| FCF Yield | -568.62% |
Analyst Forecast
The average price target for XFOR is $72.33, which is 2,065.57% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $72.33 |
| Price Target Difference | 2,065.57% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | 153.60% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
The last stock split was on April 28, 2025. It was a reverse split with a ratio of 0.0333333:1.
| Last Split Date | Apr 28, 2025 |
| Split Type | Reverse |
| Split Ratio | 0.0333333:1 |
Scores
XFOR has an Altman Z-Score of -6.88 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -6.88 |
| Piotroski F-Score | 1 |